Facebook Linkedin Tumblr Twitter
Sign in
  • My Account
  • orders
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
  • Sign in / Join
Facebook Linkedin Tumblr Twitter
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • My Account
  • orders
Home Biotech Stocks

Biotech Stocks

Random
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random
Exelixis

The Science Behind Exelixis’ Billion Dollar NDA

Jennifer Aldershot - December 30, 2015

Athersys, Inc. (NASDAQ:ATHX) Down, Maybe An Opportunity?

pfizer-inc

Pfizer Inc. (NYSE:PFE) Signs Agreement With NCI To Explore Immunotherapy

Biotech Movers: Novo Nordisk A/S (ADR) (NYSE:NVO) and EXACT Sciences Corporation (NASDAQ:EXAS)

Taking A Look At CymaBay Therapeutics Inc (NASDAQ:CBAY)’s Big Deal

Is Teva Pharmaceutical Industries Ltd (NYSE:TEVA) Planning Celltrion Takeover To Bolster...

- October 18, 2016 0
frost

Frost Closes SciVac Deal, A Potential Blockbuster Lineup in Hepatitis?

- August 5, 2015 0
Eli Lilly

What are the Implications of Eli Lilly’s FDA Black Box?

Roger Hannington - November 27, 2015 0

GlaxoSmithKline (NYSE:GSK) Partners With VBI Vaccines (NASDAQ:VBIV), SciVac (OTCMKTS:SVACF) To Eliminate...

Rafi Farber - February 17, 2016 0

Catabasis Pharmaceuticals Inc (NASDAQ:CATB): What’s Next?

- February 1, 2017 0
Perrigo Company plc

Perrigo Company plc Ordinary Shares (NYSE:PRGO) To Sell Its Active Pharma...

- August 11, 2017 0

Novartis AG (ADR)(NYSE:NVS) To Delay Spinning Off Alcon

- October 25, 2017 0
Allergan

What Allergan’s “Big Week” Really Means for its Future

Jennifer Aldershot - July 28, 2015 0

Shire PLC (ADR) (NASDAQ:SHPG) Acquires Rights to Pfizer, Inc. (NYSE:PFE) IBD...

- June 15, 2016 0
AGTC

AGTC Has A Big Advantage In The Orphan Space; And Its...

Roger Hannington - August 18, 2015 0
123...146Page 1 of 146

Latest Articles

  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

December 15, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

December 8, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

December 1, 2025

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings97015
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
Facebook Linkedin Tumblr Twitter
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019